Risk, Management, and Outcomes in PCI-Treated Acute Coronary Syndrome With Cardiogenic Shock [0.03%]
急性心源性休克冠脉综合征的经皮冠状动脉介入治疗风险、管理和预后研究
Takanori Ohata,Shun Kohsaka,Ryo Nakamaru et al.
Takanori Ohata et al.
Background: Acute coronary syndrome complicated by cardiogenic shock (ACS-CS) remains associated with high mortality despite advances in percutaneous coronary intervention (PCI) and increasing attention to mechanical circ...
Specificity of the Occlusion Myocardial Infarction-Trained PMcardio "Queen of Hearts" AI-ECG in Inflammatory Myopericardial Syndromes [0.03%]
心肌梗死训练的PMcardio "红心皇后" AI-ECG在心肌炎性心包综合征中的特异性
Wesley Bennar,Dorian Garin,Rayane M Saidi et al.
Wesley Bennar et al.
Background: Inflammatory myopericardial syndromes (IMPS)-including pericarditis, myocarditis, and overlap phenotypes-frequently present with chest pain and electrocardiographic abnormalities that can mimic occlusion myoca...
Serum Pro-N-Cadherin Correlates With Cardiac Injury in the Radiation Late Effects Cohort of Nonhuman Primates [0.03%]
放射晚期效应非人灵长类动物血清中Pro-N-钙粘蛋白与心脏损伤相关性研究
Paul D Ferrell,Drew Neish,Gregory O Dugan et al.
Paul D Ferrell et al.
Background: The delayed effects of radiation exposure on the heart often manifest as cardiac fibrosis and diastolic dysfunction, which can develop years after exposure. However, no Food and Drug Administration-approved se...
Building Collaborative Heart Failure Care Through a Community Pharmacy Certificate Program and Community Pharmacist-Physician Network [0.03%]
基于社区药房认证项目和药师-医师网络的协作性心力衰竭照护建设
Kazuhiko Kido,Amber Conrad,Ryan Vilain et al.
Kazuhiko Kido et al.
Background: Limited evidence exists on the implementation of community-based heart failure (HF) care with community pharmacists. Objectives: ...
Improving Cardiovascular Health Equity in Women: A Life Stage Approach for Longitudinal Cardiovascular Disease Prevention [0.03%]
女性心血管健康公平的终身纵向防治工程
Shantelle Bartra,Annette Ansong,Karen Aspry et al.
Shantelle Bartra et al.
Meta-Analysis of SGLT2 Inhibitors in Transthyretin Cardiac Amyloidosis: Insights by Disease-Modifying Therapy [0.03%]
SGLT2抑制剂在 ATTR心肌病中的meta分析：疾病修饰治疗的启示
Lorenzo Bianchi,Giulia Marchionni,Taras Chendey et al.
Lorenzo Bianchi et al.
Background: Sodium glucose co-transporter 2 inhibitors (SGLT2i) improve outcomes in heart failure (HF), but evidence in transthyretin cardiac amyloidosis (ATTR-CM)-particularly in patients not receiving disease-modifying ...
Public Awareness of Sex Differences in Cardiovascular Disease: A Nationwide Population Study [0.03%]
我国全国人口中关于心血管疾病性别差异的公众认知调查研究
Hyun-Jin Kim,Hack-Lyoung Kim,Sang Min Park et al.
Hyun-Jin Kim et al.
Background: Sex differences in the pathophysiology, symptoms, and outcomes of cardiovascular disease (CVD) are increasingly recognized. However, public awareness of these sex-specific differences remains underexplored, pa...
Association Between Cardiovascular Risk Factors and Pan-Coronary Plaque Burden, Phenotype, and Vulnerability: A 3-Vessel Imaging Study [0.03%]
心血管危险因素与冠状动脉斑块负担、表型和易损性关联的一项三支血管成像研究
Jakub Chmiel,Stefano Andreaggi,Sekeun Kim et al.
Jakub Chmiel et al.
Background: Cardiovascular risk factors (RFs) are commonly used in clinical practice to predict future adverse cardiovascular outcomes, including acute coronary syndromes (ACS). A recent study reported an association betw...
Puerto Rico as a Cardiovascular Equity Laboratory in the PREVENT Era [0.03%]
预防时代背景下波多黎各心血管公平性实验室的建立
Ivan Figueroa,Marcos Fernandez,Angel Davila et al.
Ivan Figueroa et al.
From Principle to Practice: A Health System Blueprint for Closing Cardiovascular Health Outcome Gaps [0.03%]
从理论到实践：缩小心血管健康结果差距的卫生系统蓝图
Jennifer H Mieres,Natalie M Cordero,Amgad N Makaryus et al.
Jennifer H Mieres et al.